Linklaters, Kirkland Rep On Takeda $414M Surgical Patch Divestment

Takeda said Wednesday it is selling off a surgical patch business for €350 million (about $414 million) to Corza Health in a deal guided by Linklaters LLP and Kirkland & Ellis LLP that...

Already a subscriber? Click here to view full article